ASGE Recognized Industry Associate (ARIA) Training Program for Regeneron | June 2022-June28 Session 11 - Pathophysiology and Current Treatment of EoE

June28 Session 11 - Pathophysiology and Current Treatment of EoE

Video Transcription

Video Summary

The video discusses the management and treatment options for eosinophilic esophagitis (EOE). The speaker explains that EOE can be treated with a combination of dietary changes, medications such as proton pump inhibitors (PPIs) and topical steroids, dilation procedures, and biologic therapies. The goal of therapy is to reduce eosinophil counts, improve symptoms, and prevent complications such as strictures. The video also mentions various biologic therapies currently in development for EOE, including Dupilumab, RPC-4046, and Budesanide oral dispersal tablets. The speaker emphasizes the importance of individualized treatment plans and the need for ongoing monitoring and follow-up to assess treatment response and adjust therapy as needed. The video highlights the challenges of managing EOE, including medication compliance, hypervigilance and anxiety about the disease, and the high risk of relapse if therapy is stopped. The overall message is that EOE is a complex condition requiring a multifaceted approach to treatment.

Asset Subtitle

Rishi Naik, MD, MSCI

Keywords

eosinophilic esophagitis

treatment options

dietary changes

biologic therapies

eosinophil counts

symptoms improvement

complications prevention

individualized treatment plans

medication compliance